Pittenger & Anderson Inc’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.2K | Hold |
115
| – | – | ﹤0.01% | 319 |
|
2025
Q1 | $25.7K | Sell |
115
-374
| -76% | -$83.7K | ﹤0.01% | 313 |
|
2024
Q4 | $160K | Buy |
489
+80
| +20% | +$26.2K | 0.01% | 231 |
|
2024
Q3 | $123K | Sell |
409
-2,547
| -86% | -$765K | ﹤0.01% | 263 |
|
2024
Q2 | $974K | Buy |
2,956
+98
| +3% | +$32.3K | 0.04% | 161 |
|
2024
Q1 | $1.13M | Buy |
2,858
+1,159
| +68% | +$459K | 0.05% | 149 |
|
2023
Q4 | $598K | Buy |
1,699
+315
| +23% | +$111K | 0.03% | 173 |
|
2023
Q3 | $519K | Buy |
1,384
+716
| +107% | +$269K | 0.03% | 164 |
|
2023
Q2 | $255K | Buy |
668
+166
| +33% | +$63.5K | 0.01% | 191 |
|
2023
Q1 | $174K | Buy |
502
+167
| +50% | +$57.9K | 0.01% | 210 |
|
2022
Q4 | $78.8K | Sell |
335
-8,611
| -96% | -$2.03M | ﹤0.01% | 250 |
|
2022
Q3 | $2.2M | Buy |
8,946
+550
| +7% | +$135K | 0.13% | 127 |
|
2022
Q2 | $2.54M | Buy |
8,396
+365
| +5% | +$110K | 0.15% | 126 |
|
2022
Q1 | $3.3M | Buy |
8,031
+190
| +2% | +$78K | 0.16% | 118 |
|
2021
Q4 | $3.68M | Buy |
7,841
+385
| +5% | +$181K | 0.17% | 116 |
|
2021
Q3 | $3.17M | Buy |
7,456
+141
| +2% | +$59.9K | 0.16% | 120 |
|
2021
Q2 | $2.63M | Buy |
7,315
+195
| +3% | +$70K | 0.13% | 131 |
|
2021
Q1 | $2.01M | Buy |
+7,120
| New | +$2.01M | 0.11% | 137 |
|